TNFRSF11A and breast carcinoma: Furthermore, the selective inhibition of RANKL by RANK-Fc not only attenuated breast tumor progression in a hormone- and carcinogen-driven mouse breast cancer model but also decreased the progression of breast cancer in a transgenic spontaneous tumor model (86).